Mental Health News

MANHASSET, N.Y.--(BUSINESS WIRE)--Scientists at Northwell Health’s Feinstein Institutes for Medical Research have uncovered a critical mechanism driving vascular cognitive impairment (VCI), the world’s second most common form of dementia after Alzheimer’s disease. Their findings, published this month in Alzheimer’s & Dementia, pinpoint the dysregulation of vasoactive neuropeptides, or key regulators of blood-vessel tone, as the root cause of microvascular dysfunction in VCI. This discovery...

MINNEAPOLIS--(BUSINESS WIRE)--Dietitian Live, a pioneering healthcare start-up that merges medical nutrition therapy with subconscious rewiring to reverse chronic disease, today announced a healthcare breakthrough showing that the human brain is the primary driver of healing in chronic metabolic disease. Through its patent-pending Quantum Mind Architecture™ program, the company has demonstrated that when subconscious beliefs are rewired from fear to love, the body’s biology naturally realigns w...

SAN MATEO, Calif.--(BUSINESS WIRE)--Baszucki Group and University of Maryland School of Medicine launch ketogenic metabolic therapy training for mental health clinicians....

LOS ANGELES--(BUSINESS WIRE)--SimplePractice, the most comprehensive practice management and EHR trusted by more than 250,000 mental health practitioners, today announced the formation of its Clinical Advisory Board. Bringing together leaders across psychology, psychiatry, data science, and population health, the board will provide external expertise to guide product innovation and ensure clinical accuracy. Led by SimplePractice’s Head of Clinical Strategy, Lindsay Oberleitner, PhD, LP, the boa...

SEOUL, South Korea--(BUSINESS WIRE)--Famenity's BF-7® gains global attention as a cognitive-health ingredient backed by more than 12 human studies and major regulatory approvals....

LOS ANGELES--(BUSINESS WIRE)--As digital spaces grow increasingly volatile, a new U.S. survey from Communia, a healthy social networking app for women and non-binary people, reveals how unsafe—and unseen—many women still feel online. According to the survey commissioned by Communia1 of 2000 people in the U.S. who identify as women, including transgender women and non-binary individuals, roughly 46% report they have been a victim of online abuse and, even if they haven’t personally been victimiz...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that the company will present and participate in the Sachs Associates 9th Annual Neuroscience Innovation Forum on January 11, 2026 during “J.P. Morgan Week 2026” in San Francisco. Additionally, Enveric will attend Biotech Showcase 2026, which is b...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that on December 2, 2025, the Compensation and Management Development Committee of Alto’s Board of Directors granted a new employee an option to purchase 150,000 shares of Alto’s common stock. The stock option was granted under Alto’s 2025 Inducement Plan as a mate...

AUSTIN, Texas & SAN FRANCISCO--(BUSINESS WIRE)--Serent Capital announces Axiom Medical’s recapitalization and new growth investment from NMS Capital after a seven-year partnership....

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present eight posters at the American Epilepsy Society (AES) Annual Meeting, taking place Dec. 5-9 in Atlanta. These presentations highlight real-world evidence from the CORE-VNS study, the largest prospective, multinational observational study of VNS Therapy™ for Drug-Resistant Epilepsy (DRE), and new health economics analyses. “At the heart of LivaNova’s purpose as a Comp...